-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_tables.xlsx
January 01, 2009 - 32.03% 15.58%
Gender Male 2009 0.43% 0.12% 37.80% 5.25% 0.95% 23.09% 1.76% 30.69% 14.04%
Gender … 48.83% 23.74%
Gender Male 2009 0.66% 0.19% 57.25% 7.95% 1.44% 34.98% 2.66% 46.48% 21.26%
Gender … 2.22% 3.36% 30.86% 24.60%
Gender Male 2008 0.71% 0.57% 32.85% 4.98% 1.99% 3.07% 30.43% 17.61%
Gender … Gender Female 2008 0.65% 0.65% 32.03% 5.08% 2.10% 3.19% 28.77% 15.17%
Gender Female 2009 0.61% 0.59% … 1.59% 3.25% 60.51% 34.28%
Gender Male 2008 0.68% 0.02% 67.29% 7.33% 1.55% 2.99% 58.35% 26.92%
Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
February 01, 2011 - These rates varied by age, gender, race/ethnicity, and geographic
location. … 74 26.4 27.2 27.7
75 to 84 28.0 29.0 29.8
85 to 94 24.1 25.1 25.9
95 and over 16.7 17.5 18.1
Gender … These rates
varied by age, gender, race/ethnicity, and
geographic location. … These rates varied by age, gender,
race/ethnicity, and geographic location. … Gender, race/ethnicity,
and age were all extracted from the EDB.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
August 01, 2020 - Does the effectiveness of the MAT retention strategy vary by participant
characteristics (e.g., age, gender … The study
10
of the prerelease MAT with office-based buprenorphine in a PC setting found no gender … assess differential effectiveness of CM on retention by defined
participant characteristics (e.g., gender … : 42.5% female
Control group:
Gender: 53% female
Naltrexone
injections
26 weeks
Retention: … Fair
Weintraub,
201826
Retrospective
chart review
USA
177
Mean Age: 35.1
Gender: 89% male
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
March 01, 2011 - Continued from previous page
Variable Year Biguanides Insulins Sulfonylureas Thiazolidinediones
Gender … Enrollment status as well as
gender, race/ethnicity, and age were identified in
the EDB. … Parts A, B, and D
FFS Population With Diabetes and At Least One Antidiabetic Drug Order, by
Age, Gender … Class, Among Medicare Parts A, B, and
D FFS Population With Diabetes and No Insulin Claim, by Age, Gender … Medicare Parts A, B, and
D FFS Population With Diabetes and At Least One Biguanide Claim, by Age,
Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-h.xlsx
January 01, 2023 - exposure-based CBT Yes Yes 20 13 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score Gender … /not specified NR Yes Yes 6 42 Adequate OCD symptom severity CY-BOCS (continuous) percent reduction Gender … specified NR Yes Yes 6 63 Adequate Family Accommodation Family Accommodation/FAS postreatment score Gender … ERP/Exposure CBT Yes Yes 4 25 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score Gender … ERP/Exposure CBT Yes Yes 4 15 Adequate OCD symptom severity CY-BOCS (continuous) postreatment score Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
January 09, 2020 - effectiveness of opioid therapy vary depending on: (1) patient demographics
(e.g. age, race, ethnicity, gender … nonopioid pharmacologic therapy vary depending on: (1)
patient demographics (e.g. age, race, ethnicity, gender … does effectiveness of nonpharmacologic therapy vary depending on: (1) patient
demographics (e.g. age, gender … <1 week; 1 week
to <2 weeks; 2 weeks to 4 weeks), patient demographics (e.g. age, race, ethnicity, gender … been identified, including patient factors
(e.g., demographic characteristics (age, race, ethnicity, gender
-
effectivehealthcare.ahrq.gov/sites/default/files/c-diff-infections-nomination-140925.pdf
February 19, 2014 - Does effectiveness vary by patient characteristics: gender … § Does effectiveness vary by patient characteristics: age, gender, comorbidity, hospital- versus
community-acquired
-
effectivehealthcare.ahrq.gov/sites/default/files/cultural-competence_disposition-comments.pdf
January 01, 2020 - We have
also made several changes to avoid
conflating gender identification with
sexual orientation … identity information in surveys. … Would it be more trans inclusive to add ...and/or gender transition
after ...sexual behaviors So it … would read Knowing what problems
may be associated with sexual behaviors and/or gender transition. … identity If I remember
correctly MEPS is linkable to the National Health Interview Survey
NHIS and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
June 01, 2020 - participant subgroups defined by participant
characteristics (e.g., race/ethnicity, socioeconomic
status, gender … with
participant characteristics, e.g., reporting correlations
with a factor of interest such as gender … Native Hawaiians and other Pacific Islanders);
socioeconomic status; underserved rural populations; gender … ; sexual and gender
minorities; and educational attainment.7, 8 In addition, we will use an unselected … Variables will include study ID, country,
participant characteristics, disparity category (e.g., gender
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
January 01, 2009 - 78.2% 17.9 90.1% 2.0 1.3
85 and over 2006 13.6 10.5 77.2% 10.9 79.7% 9.4 89.3% 2.0 1.2
Gender … 72.4% 29.8 89.3% 2.0 1.3
85 and over 2007 26.0 17.6 67.5% 17.9 68.9% 15.7 89.4% 2.0 1.2
Gender … 69.4% 30.4 89.6% 2.0 1.3
85 and over 2008 31.0 18.5 59.5% 18.7 60.2% 16.6 89.7% 2.0 1.2
Gender … 85 and over 2006 3.3 31.6 1.6 14.7 3.5 33.5 5.2 49.2 4.5 42.5 0.9 8.2 0.2 1.8 0.0 0.1 2.0 18.8
Gender … 85 and over 2007 5.5 31.3 2.6 14.8 5.8 33.1 8.3 47.2 7.9 45.1 1.4 7.8 0.3 1.8 0.0 0.2 3.5 20.1
Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0373-14083.pdf
July 09, 2014 - Topic 0315 Disparities and SMI NSD SJ clean
Interventions to Reduce Disparities among
Patients with Serious Mental Illness
Nomination Summ…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
January 01, 2020 - Islanders), socioeconomically disadvantaged populations,
underserved rural populations, sexual and gender … Islanders), socioeconomically disadvantaged populations, underserved rural populations, sexual and gender … identity/
8 exp sexual orientation/
9 (divers* or minorit* or ethnicit* or race or racial … identity" OR DE "ANDROGYNOUS identity" OR DE
"FEMININE identity" OR DE "GENDER identity & clothing" … OR DE "GENDER
identity in education" OR DE "GENDER identity in mass media" OR DE
"INTERSEXUAL identity
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - Do the effect estimates of clinical cardiovascular
outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of intermediate cardiovascular
outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of harms outcomes vary by age,
ethnicity, gender, or health status?
b. … Do the effect estimates of pharmacokinetic outcomes
vary by age, ethnicity, gender, or health status … They should also collect data and undertake subgroup
analysis for age, gender, race, comorbidities (
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - with logistic regression models using baseline characteristics
including age (5-year age groups), gender … Each of these models adjusted for age, gender, race, income,
primary site of cancer, Charlson score, … fRate from Earle et al were standardized according to the distribution of age, gender, and cancer type … aVariables included in Patient Model were: age, gender, race, income, primary site of cancer, Charlson … cVariables included in Hospital Model were: age, gender, race, income, primary site of cancer, Charlson
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
December 20, 2011 - c) What determinants affect the test performance of BNP and NT-proBNP (e.g., age,
gender, comorbidity … c) What determinants affect the test performance of BNP and NT-proBNP (e.g., age,
gender, comorbidity … Details of the patient
population will include but not be limited to age, gender (% female), racial … Were potential confounders (i.e., age, gender) measured and adequately
addressed in the analysis? … Were potential confounders (i.e., age, gender) measured and adequately
addressed in the analysis?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
August 10, 2010 - Details of the patient population will include but not be limited to
age, gender, racial composition … www.effectivehealthcare.ahrq.gov
Published Online: August 10, 2010
clinical diversity (e.g., study population gender … be assessed by
considering any potential differences in participants amongst the trials (e.g., age
gender … can be undertaken) and these can include
the following: 1) disease severity (within ADHD only), 2) gender
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
February 01, 2023 - give birth or feed their
infants human milk identify as a woman or mother.39-41 Transgender men and gender … As such, the word “breastfeeding” itself may be less accurate for gender-diverse parents,
who may prefer … As studies report on populations and infant feeding in more gender-inclusive language, we
will bring … Transmasculine individuals' experiences with
lactation, chestfeeding, and gender identity: a qualitative … Breastfeeding Medicine Position
Statement and Guideline: Infant Feeding and Lactation-Related Language and Gender
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
January 01, 2011 - Staff-Generated PICO
Population(s): Patients with pulmonary arterial hypertension; no exclusions for age,
gender
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
January 01, 2008 - Are there subgroups of patients based on demographics (age, racial groups,
gender), other medications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
January 31, 2023 - Some studies report disparities in the diagnosis and treatment of DBDs due to such factors as
gender … for disruptive behaviors vary in effectiveness and harms
based on patient characteristics, including gender … the disparities in the diagnosis of disruptive behavior disorders
(based on characteristics such as gender … treatment of disruptive behaviors or
disruptive behavior disorders (based on characteristics such as gender … We will also abstract available participant characteristics (e.g., age, gender, race, family
history